Susquehanna International Group
TARO

Susquehanna International Group’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Susquehanna International Group’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-6,668
Closed -$281K – 13685
2023
Q4 		$279K Buy
+6,668
New +$246K ﹤0.01% 9975
2023
Q3 		– Sell
-8,486
Closed -$322K – 13252
2023
Q2 		$322K Buy
+8,486
New +$266K ﹤0.01% 9288
2022
Q4 		– Sell
-9,169
Closed -$275K – 14032
2022
Q3 		$275K Sell
9,169
-731
-7% -$25.2K ﹤0.01% 10016
2022
Q2 		$358K Buy
+9,900
New +$377K ﹤0.01% 9081
2020
Q3 		– Sell
-4,504
Closed -$299K – 11295
2020
Q2 		$299K Buy
4,504
+461
+11% +$30.9K ﹤0.01% 8373
2020
Q1 		$247K Buy
4,043
+1,415
+54% +$105K ﹤0.01% 8331
2019
Q4 		$231K Buy
+2,628
New +$222K ﹤0.01% 8507
2018
Q1 		– Sell
-48,737
Closed -$5.1M – 10370
2017
Q4 		$5.1M Buy
48,737
+38,542
+378% +$4.23M ﹤0.01% 2516
2017
Q3 		$1.15M Buy
10,195
+5,000
+96% +$544K ﹤0.01% 5030
2017
Q2 		$582K Buy
5,195
+1,894
+57% +$214K ﹤0.01% 6363
2017
Q1 		$385K Buy
3,301
+604
+22% +$66.8K ﹤0.01% 6960
2016
Q4 		$284K Sell
2,697
-510
-16% -$53.4K ﹤0.01% 8074
2016
Q3 		$354K Sell
3,207
-18,805
-85% -$2.49M ﹤0.01% 6652
2016
Q2 		$3.21M Buy
22,012
+8,697
+65% +$1.23M ﹤0.01% 2824
2016
Q1 		$1.91M Buy
13,315
+279
+2% +$39.6K ﹤0.01% 3865
2015
Q4 		$2.02M Buy
13,036
+2,249
+21% +$328K ﹤0.01% 4020
2015
Q3 		$1.54M Sell
10,787
-15,157
-58% -$2.12M ﹤0.01% 4817
2015
Q2 		$3.73M Buy
25,944
+6,244
+32% +$890K ﹤0.01% 3454
2015
Q1 		$2.78M Sell
19,700
-1,811
-8% -$279K ﹤0.01% 3695
2014
Q4 		$3.19M Buy
21,511
+12,504
+139% +$1.84M ﹤0.01% 3637
2014
Q3 		$1.39M Buy
9,007
+5,727
+175% +$862K ﹤0.01% 5285
2014
Q2 		$460K Buy
+3,280
New +$364K ﹤0.01% 7635

Other funds holding TARO

KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
AIIMS
Analyst IMS Investment Management Services Tel-Aviv, Israel $4.3B AUM 37.33% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
LI
LRI Investments Palm Beach Gardens, Florida $1.24B AUM 11.13% 1-Year Est. Return
GCM
Gladius Capital Management Chicago, Illinois $1.65B AUM 25.75% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
LC
Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return

Susquehanna International Group's TARO Position: Q1 2024 in Review

Susquehanna International Group sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q1 2024, closing a stake of 6,668 shares — an estimated $281K sold.

Susquehanna International Group first reported a position in TARO in Q2 2014 and held it in 22 quarters. The position peaked at $5.1M in Q4 2017. 94 funds tracked by Wall St. Rank hold TARO as of Q1 2024.

  • Susquehanna International Group reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q1 2024 after selling out during the quarter.
  • Susquehanna International Group sold 6,668 Taro Pharmaceutical Industries Ltd. shares in Q1 2024, an estimated $281K.
  • Susquehanna International Group first reported a position in Taro Pharmaceutical Industries Ltd. in Q2 2014 and held it in 22 quarters.
  • Susquehanna International Group's Taro Pharmaceutical Industries Ltd. position peaked at $5.1M in Q4 2017.
  • 94 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q1 2024.

Based on Susquehanna International Group's 13F filing for Q1 2024, filed 7 May 2024.